Number of the records: 1  

[5-(Benzyloxy)-1H-indol-1-yl]acetic acid, an aldose reductase inhibitor and PPARγ ligand

  1. Title[5-(Benzyloxy)-1H-indol-1-yl]acetic acid, an aldose reductase inhibitor and PPARγ ligand
    Author Šoltésová Prnová Marta 1986- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV    SCOPUS    ORCID
    Co-authors Májeková Magdaléna 1958- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV    SCOPUS    RID    ORCID

    Miláčková Ivana 1985- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV    SCOPUS    SCOPUS

    Diez-Dacal Beatriz

    Pérez-Sala Gozalo Dolores

    Ceyhan Seyma Muserref

    Banerjee Sreeparna

    Štefek Milan 1950-2023 SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV    SCOPUS    ORCID

    Source document Acta Biochimica Polonica. Vol. 62, no. 3 (2015), p. 523-528
    Languageeng - English
    CountryPL - Poland
    NoteMINECO-DPS SAF2012-36519
    Document kindrozpis článkov z periodík (rbx)
    CitationsSEBASTIAN, J. Structure-Activity relationship study reveals benzazepine derivatives of luteolin as new aldose reductase inhibitors for diabetic cataract. In CURRENT DRUG DISCOVERY TECHNOLOGIES. ISSN 1570-1638, 2016, vol. 13, no. 3, p. 152-163.
    SARI, D.R.T. - CAIRNS, J.R.K. - SAFITRI, A. - FATCHIYAH, F. Virtual prediction of the delphinidin-3-o-glucoside and peonidin-3-o-glucoside as anti-inflammatory of TNF-α signaling. In ACTA INFORMATICA MEDICA. ISSN 0353-8109, 2019, vol. 27, no. 3, p. 152-157.
    KOUSAXIDIS, A. - PETROU, A. - LAVRENTAKI, V. - FESATIDOU, M. - NICOLAOU, I. - GERONIKAKI, A. Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus. In EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. ISSN 0223-5234, 2020, vol. 207, art. no. 112742.
    LIU, K. - ZHAO, X. - QI, X. - HOU, D.L. - LI, H.B. - GU, Y.H. - XU, Q.L. Design, synthesis, and biological evaluation of a novel dual peroxisome proliferator-activated receptor alpha/delta agonist for the treatment of diabetic kidney disease through anti-inflammatory mechanisms. In EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. ISSN 0223-5234, 2021, vol. 218.
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2015
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.18388/abp.2014_953
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201520141.153Q40.511Q2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.